ProA Study: ProActive Management Model in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated by Apalutamide
Clinical trial NCT06865547 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06865547
- Sponsor
- Yonghong Li
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-22
- Primary completion
- 2026-01-30
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.